← Leaderboards
Karen Kotloff
University Of Maryland Baltimore
$13,373,636
Attributed
$13,373,636
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.6M · FY2016–22$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$13,373,636 · 1
By mechanism
N01$13,373,636 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Nicholas H. Carbonetti$11,852,037
- Karen L. Kotloff$76,457,208
- Claudia Rose Baquet$15,865,421
- Marcela F Pasetti$26,884,335
- Myron Max Levine$22,681,817
Others in their field
Top investigators on “Communicable Diseases”
- Jeffrey P Krischer · University Of South Florida$580,775,398
- Judith S. Currier · University Of California Los Angeles$277,419,428
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$240,302,862
- Melynda Holmes · Technical Resources Inc$231,847,503
- Lawrence Corey · Fred Hutchinson Cancer Center$228,424,910
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
Research focus
Communicable DiseasesConduct Clinical TrialsContractsResourcesDesignCombatProgramsNamed GroupEvaluationVaccinesProtocol DevelopmentVaccine TrialOperationVaccine Clinical TrialPhase I Clinical TrialsInfluenza Virus VaccineInfluenza A VirusAntimicrobial ResistanceClinical Trials NetworkPhase I TrialInfluenzaAnthrax VaccinesBacillus AnthracisMalaria Vaccines
Grant awards (28)
Vaccine and Treatment Evaluation Units: Administration Support$149,143
N01 · FY2022 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS (VTEU): PROTOCOL DEVELOPMENT AND IMPLEMENTATION, FOR A PHASE 1 ANTHRAX VACCINE TRIAL$23,948
N01 · FY2022 · AI · contact PI
VTEU: PHASE II VACCINE TRIAL FOR INFLUENZA$5,000
N01 · FY2022 · AI · contact PI
Vaccine and Treatment Evaluation Units: Administration Support$146,226
N01 · FY2021 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS (VTEU): PROTOCOL DEVELOPMENT AND IMPLEMENTATION, FOR A PHASE 1 ANTHRAX VACCINE TRIAL$952,381
N01 · FY2020 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS: PHASE I INFLUENZA VACCINE CLINICAL TRIAL$262,361
N01 · FY2020 · AI · contact PI
Vaccine and Treatment Evaluation Units: Administration Support$144,903
N01 · FY2020 · AI · contact PI
VTEU: Malaria Vaccine Studies$23,870
N01 · FY2020 · AI · contact PI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Natural History Challenge Study for Influenza$1,601,464
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Phase I Trial for Influenza Vaccine.$995,111
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Administration Support$358,696
N01 · FY2019 · AI · contact PI
Vaccine and Therapeutic Evaluation Units: POPULATION PHARMACOKINETIC ANALYSES$302,123
N01 · FY2019 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS (VTEU): PROTOCOL DEVELOPMENT AND IMPLEMENTATION, FOR A PHASE 1 ANTHRAX VACCINE TRIAL$159,112
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Vaccine and Treatment Evaluation Units: Clinical Research Studies for Filariasis Therapeutics$139,648
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Vaccine and Treatment Evaluation Units: Clinical Research Studies for Malaria Therapeutics$139,648
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Unit - Clinical Operations Support$356,171
N01 · FY2018 · AI · contact PI
VTEU: POPULATION PHARMACOKINETIC ANALYSES$324,406
N01 · FY2018 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS: PHASE I INFLUENZA VACCINE CLINICAL TRIAL$39,235
N01 · FY2018 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS - PHASE I STUDY TO EVALUATE THERAPEUTICS FOR RESISTANT BACTERIAL INFECTIONS$6,320
N01 · FY2018 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNIT: POPULATION PHARMACOKINETIC ANALYSES$1,397,685
N01 · FY2017 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNITS: CONCEPT AND PROTOCOL DEVELOPMENT$595,200
N01 · FY2017 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT: CLINICAL OPERATIONS SUPPORT$339,469
N01 · FY2017 · AI · contact PI
Vaccine Treatment and Evaluation Unit: Phase IV Tuberculosis Therapeutics Trial$217,479
N01 · FY2017 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS: PHASE I INFLUENZA VACCINE CLINICAL TRIAL$80,427
N01 · FY2017 · AI · contact PI
VTEU: Malaria Vaccine Studies$2,791,483
N01 · FY2016 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS: PHASE I INFLUENZA VACCINE CLINICAL TRIAL$1,322,957
N01 · FY2016 · AI · contact PI
VTEU: STI Diagnostic Studies$367,673
N01 · FY2016 · AI · contact PI
VACCINE AND TREATMENT EVALUATION$131,497
N01 · FY2016 · AI · contact PI